Hannah Joseph Hospital Confirms Zero Deviation in IPO Proceeds Utilization for H1FY27
Hannah Joseph Hospital Ltd · Others (Uncategorized) · 05 Nov 2026, 6:47 pm
Hannah Joseph Hospital Confirms Zero Deviation in IPO Proceeds Utilization for H1FY27 Hannah Joseph Hospital Limited reported nil deviation in the utilization of its IPO proceeds for the half year ended 30th Sep'26. Out of the total ₹4,200 lakh raised on 29th Jan'26, the company utilized ₹840.33 lakh, leaving ₹3,359.67 lakh unutilized. Deployments include ₹152.80 lakh of the planned ₹3,498.21 lakh capex for Radiation Oncology, ₹32.15 lakh for general corporate purposes, and ₹655.38 lakh toward issue expenses. Gross fixed deposit interest of ₹31.50 lakh from Kotak Mahindra Bank remains excluded from the unutilized balance.
Original exchange filing (PDF)
More announcements from Hannah Joseph Hospital Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daniel Dayanand Fenn & PACs · 17 Nov 2026
- Unaudited Financial Results for the Half year ended 30th September, 2026 · 05 Nov 2026
- The Board of Directors of the Company at their meeting held on 05.11.2026, inter alia, approved the Unaudited Financial Results for the half year ended 30th September, 2026. · 05 Nov 2026
- Hannah Joseph Hospital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial .... · 05 Nov 2026
- Disclosure under Regulation 30 of the SEBI (LODR) Regulations, 2015 regarding Significant Milestones achieved by Hannah Jospeh Hospital in Advanced Neurovascular Care. · 28 Oct 2026
- We are pleased to inform you that Hannah Joseph Hospital Limited, has been awarded the "Honours for Healthcare Excellence in Neurosciences" at CII TN MedClave 2026, held on 24th October .... · 26 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daniel Dayanand Fenn & PACs · 29 Sept 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Daniel Dayanand Fenn & PACs · 21 Sept 2026
